Q4 2021 Holdings
Filed 2022-02-11 | 10 holdings | $462.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $134.3K | 2,885,470 | 29.0% |
| Entrada Therapeutics, Inc.(TRDA) | Common | 29384C108 | $75.8K | 4,425,784 | 16.4% |
| Dyne Therapeutics, Inc.(DYN) | Common | 26818M108 | $58.9K | 4,951,303 | 12.7% |
| Werewolf Therapeutics, Inc.(HOWL) | Common | 95075A107 | $51.0K | 4,284,172 | 11.0% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $47.3K | 2,242,636 | 10.2% |
| Amryt Pharma plc | Common | 03217L106 | $28.8K | 2,668,843 | 6.2% |
| Harpoon Therapeutics, Inc. | Common | 41358P106 | $23.6K | 3,131,388 | 5.1% |
| Tcr2 Therapeutics, Inc. | Common | 87808K106 | $18.9K | 4,050,865 | 4.1% |
| Oncorus, Inc. | Common | 68236R103 | $15.0K | 2,849,464 | 3.2% |
| Rhythm Pharmaceuticals, Inc.(RYTM) | Common | 76243J105 | $9.1K | 909,258 | 2.0% |